scholarly journals Progressive cerebral atrophy in multiple sclerosis A serial MRI study

Brain ◽  
1996 ◽  
Vol 119 (6) ◽  
pp. 2009-2019 ◽  
Author(s):  
N. A. Losseff ◽  
L. Wang ◽  
H. M. Lai ◽  
D. S. Yoo ◽  
M. L. Gawne-Cain ◽  
...  
2009 ◽  
Vol 15 (1) ◽  
pp. 114-115 ◽  
Author(s):  
P Valentino ◽  
A Labate ◽  
R Nisticò ◽  
D Pirritano ◽  
A Cerasa ◽  
...  

Objectives The aim of this study was to correlate the brain atrophy with serum levels of anti-GM1 antibodies in patients with relapsing–remitting multiple sclerosis (RRMS). Methods Plasma sample from 52 patients with RRMS and 65 healthy controls were examined for anti-GM1 antibodies. Patients with RRMS underwent to MRI study with automated method called SIENAX that calculated an estimate of gray matter (GMV) and white matter (WMV) volumes. Results The percentage of RRMS patients with increased anti-GM1 was 37.8%. Elevated levels of anti-GM1 antibodies did not correlate with brain atrophy. Conclusions Anti-GM1 antibodies do not represent a marker of axonal damage in patients with RRMS.


1995 ◽  
Vol 56-63 ◽  
pp. 44-44
Author(s):  
JW Thorpe ◽  
AJ Thompson ◽  
IF Moseley ◽  
DAS Compston ◽  
WI McDonald ◽  
...  
Keyword(s):  

2008 ◽  
Vol 32 (9) ◽  
pp. 769-777 ◽  
Author(s):  
Michael M. Millner ◽  
Franz Ebner ◽  
Erwin Justich✠ ◽  
Christian Urban

2021 ◽  
Vol 429 ◽  
pp. 117667
Author(s):  
Claudio Cordani ◽  
Paola Valsasina ◽  
Alessandro Meani ◽  
Elisabetta Pagani ◽  
Tetsu Morozumi ◽  
...  

2018 ◽  
Vol 40 (1) ◽  
pp. 99-106 ◽  
Author(s):  
G. Pontillo ◽  
S. Cocozza ◽  
R. Lanzillo ◽  
C. Russo ◽  
M.D. Stasi ◽  
...  

2019 ◽  
Vol 19 (2) ◽  
pp. 148-153
Author(s):  
Oranan Tritanon ◽  
Arunee Singhsnaeh ◽  
Jiraporn Laothamatus ◽  
Atthaporn Boongird ◽  
Disya Ratanakorn ◽  
...  

Tumefactive multiple sclerosis is a form of demyelinating disease which patient can present with acute stroke. We reported a case of a 49-year-old woman with well controlled hypertension, who presented with right hemiplegia 15 hours prior to admission. The initial diagnosis of acute stroke was made. Emergency computed tomography showed hypodense lesion at the left lentiform nucleus and posterior limb of the left internal capsule. The magnetic resonance imaging (MRI) study showed hyperintense FLAIR lesion in the left lentiform nucleus, left internal capsule, left thalamus, and periventricular area of the left frontoparietal region, some areas of restricted diffusion and inhomogeneous enhancement. The MR spectroscopy (MRS) of the lesion showed increased choline peak, decreased creatine and NAA peaks, and maximal choline to creatine ratio 2.25. Her symptoms deteriorated with progressive headache and motor aphasia. The follow up MRI showed extension of the inhomogeneous enhancing lesion along the biopsy tract at the left frontal lobe with the enhancing and MR spectra pattern similar to the lesion. The craniotomy with left frontal lesion excision included the mass and the biopsy tract was done. The lesion showed acute and chronic inflammatory cell infiltration with macrophages, necrotic tissue and reactive gliosis. The further pathological worked up demonstrated foci of demyelination with relative axonal preservation, numerous CD68+ macrophages with intracyto-plasmic Luxol fast blue(+) myelin debris. Perivascular and parenchymal CD3+ T-cells were identified, especially in demyelinating foci. These findings supported the diagnosis of tumefactive multiple sclerosis. Her conditions were improved after treating with pulse methylprednisolone and intravenous immunoglobulin (IVIG). Follow up MRI study 4 months after treatment revealed almost resolution of the preexisting inhomogeneous enhancing lesion.


Sign in / Sign up

Export Citation Format

Share Document